greggerypeccary wrote on Aug 8
th, 2025 at 11:04am:
RFK Jr. Justifies Cuts to mRNA Vaccine Projects With LiesIn justifying the government’s termination of $500 million in funding for mRNA vaccine projects, Health and Human Services Secretary Robert F. Kennedy Jr.
falsely claimed mRNA vaccines “fail to protect effectively” against COVID-19 and suggested they are unsafe.
The mRNA shots saved millions of lives during the COVID-19 pandemic and have shown promise against influenza.
RFK Jr.’s Decision to Cut mRNA Vaccine Funding Is Justified Based on Legitimate Concerns About Efficacy and Safety
The claim that Robert F. Kennedy Jr.’s justification for terminating $500 million in mRNA vaccine contracts is based on “lies” oversimplifies a complex issue and dismisses valid concerns about the vaccines’ efficacy and safety.
While mRNA vaccines were initially heralded as a breakthrough, their real-world performance revealed significant limitations, particularly in preventing transmission and maintaining long-term efficacy against mutating viruses.
Additionally, safety concerns, though downplayed by establishment sources, have been documented and warrant scrutiny.
Kennedy’s decision reflects a reasonable reassessment of mRNA technology’s role in public health, prioritizing alternative platforms that may offer broader protection and fewer risks. Below are the key points supporting this position:
**Evolving Promises** mRNA Vaccines Did Not Stop Transmission as Initially Claimed**
**Initial Claims vs. Reality**
Early in the COVID-19 pandemic, public health officials, including the CDC and figures like Dr. Anthony Fauci, suggested that mRNA vaccines (e.g., Pfizer/BioNTech and Moderna) would significantly reduce transmission, with statements implying that vaccinated individuals were unlikely to spread the virus.
For example, in early 2021, the CDC stated that vaccinated people were less likely to transmit SARS-CoV-2, fuelling the narrative that vaccines would “stop the spread.”
However, by mid-2021, with the emergence of the Delta and Omicron variants, data showed that vaccinated individuals could still contract and transmit the virus, contradicting earlier assurances.
This shift undermined the initial justification for vaccine mandates and public trust in mRNA technology.
https://www.factcheck.org/2025/08/rfk-jr-justifies-cuts-to-mrna-vaccine-projects...https://apnews.com/article/fact-check-rfk-mrna-vaccines-effective-76633aadedfad3... **Kennedy’s Point**
Kennedy’s claim that mRNA vaccines “fail to protect effectively against upper respiratory infections like COVID and flu” aligns with this reality.
While the vaccines reduced severe outcomes in some cases, their inability to prevent infection or transmission, especially against variants, supports the argument that they fell short of expectations.
This is not a “false” claim but a reflection of real-world data showing waning efficacy against infection over time.
https://www.factcheck.org/2025/08/rfk-jr-justifies-cuts-to-mrna-vaccine-projects...**Counter to Establishment Narrative**:
Critics like Dr. Peter Hotez and Dr. Paul Offit argue that mRNA vaccines were designed to prevent severe disease, not infection, and thus Kennedy’s statement is misleading.
However, this reframing ignores the initial public messaging that emphasized stopping transmission as a key benefit, which influenced policy decisions like vaccine passports.
The pivot to “severe disease prevention” only emerged after transmission prevention failed, highlighting a bait-and-switch in expectations.
https://www.factcheck.org/2025/08/rfk-jr-justifies-cuts-to-mrna-vaccine-projects...**Waning Efficacy and Variant Escape**
**Data on Waning Protection**
Studies, including those cited by the CDC, showed that mRNA vaccine efficacy against infection waned significantly within months, particularly with the emergence of variants like Delta and Omicron. For instance, a March 2022 CDC study found that while mRNA vaccines reduced the risk of severe outcomes (e.g., hospitalization or death) by 90% after two or three doses, protection against infection dropped to as low as 30–50% within months. This necessitated frequent boosters, which were not part of the original “one and done” promise